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Abstract
Evidence synthesis models that combine multiple datasets of varying design, to estimate
quantities that cannot be directly observed, require the formulation of complex prob-
abilistic models that can be expressed as graphical models. An assessment of whether
the different datasets synthesised contribute information that is consistent with each
other, and in a Bayesian context, with the prior distribution, is a crucial component
of the model criticism process. However, a systematic assessment of conflict suffers
from the multiple testing problem, through testing for conflict at multiple locations in
a model. We demonstrate the systematic use of conflict diagnostics, while accounting
for the multiple hypothesis tests of no conflict at each location in the graphical model.
The method is illustrated by a network meta-analysis to estimate treatment effects in
smoking cessation programs and an evidence synthesis to estimate HIV prevalence in
Poland.
KEYWORDS: Conflict; evidence synthesis; graphical models; model criticism; multiple
testing; network meta-analysis.
1 Introduction
Evidence synthesis refers to the use of complex statistical models that combine multiple, dis-
parate and imperfect sources of evidence to estimate quantities on which direct information
is unavailable or inadequate (e.g. Ades and Sutton, 2006; Welton et al., 2012; De Angelis
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et al., 2014). Such evidence synthesis models are typically graphical models represented by a
directed acyclic graph (DAG) G(V ,E), where V and E are sets of nodes and edges respec-
tively, encoding conditional independence assumptions (Lauritzen, 1996). With increased
computational power, models of the form of G(V ,E) have proliferated, requiring also the
development of model criticism tools adapted to the challenges of evidence synthesis. In
a Bayesian framework, any of the prior distribution, the assumed form of the likelihood
and structural and functional assumptions may conflict with the observed data or with each
other. To assess the consistency of each of these components, various mixed- or posterior-
predictive checks have been proposed. In particular, the “conflict p-value” (Marshall and
Spiegelhalter, 2007; G˚asemyr and Natvig, 2009; Presanis et al., 2013; G˚asemyr, 2016) is a
diagnostic calculated by splitting G(V ,E) into two independent sub-graphs (“partitions”)
at a particular “separator” node φ, to measure the consistency of the information provided
by each partition about the node (a “node-split”). G˚asemyr and Natvig (2009) and Presanis
et al. (2013) demonstrate how the conflict p-value may be evaluated in different contexts,
including both one- and two-sided hypothesis tests, and G˚asemyr (2016) demonstrates the
uniformity of the conflict p-value in a wide range of models.
The conflict p-value may be used in a targeted manner, searching for conflict at particular
nodes in a DAG. However, in complex evidence syntheses, often the location of potential
conflict may be unclear. A systematic assessment of conflict throughout a DAG is then
required to locate problem areas (e.g. Krahn et al., 2013). Such systematic assessment,
however, suffers from the multiple testing problem, either through testing for conflict at
each node in G(V ,E) or through the separation of G(V ,E) into more than two partitions
to simultaneously test for conflict between each pair-wise partition. Here we account for
these multiple tests by adopting the general hypothesis testing framework of Hothorn et al.
(2008); Bretz et al. (2011), allowing for simultaneous multiple hypotheses in a parametric
setting. They propose different possible tests to account for multiplicity: we concentrate
here on maximum-T type tests.
In section 2, we define evidence synthesis before introducing the particular models that
motivate our work on systematic conflict assessment: a network meta-analysis and a model
for estimating HIV prevalence. Section 3 describes the methods we use to test for conflict
and account for the multiple tests we perform. We apply these methods to our examples in
Section 4 and end with a discussion in Section 5.
2 Motivating examples
Formally, our goal is to estimate K basic parameters θ = (θ1, . . . , θK) given a collection of N
independent data sources y = (y1, . . . ,yN), where each yi, i ∈ 1, . . . , N may be a vector or
array of data points. Each yi provides information on a functional parameter ψi (or poten-
tially a vector of functions ψi). When ψi = θk is the identity function, the data yi are said
to directly inform θk. Otherwise, ψi = ψi(θ) is a function of multiple parameters in θ: the yi
therefore provide indirect information on these parameters. Given the conditional indepen-
dence of the datasets yi, the likelihood is L(θ;y) =
∏N
i=1 Li(ψi(θ);yi), where Li(ψi(θ);yi)
is the likelihood contribution of yi given the basic parameters θ. In a Bayesian context,
for a prior distribution p(θ), the posterior distribution p(θ | y) ∝ p(θ)L(θ;y) summarises
all information, direct and indirect, on θ. Let ψ = (ψ1, . . . , ψN) be the set of functional
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parameters informed by data and φ = {θ,ψ} be the set of all unknown quantities, whether
basic or functional. In this setup, the DAG G(V ,E) representing the evidence synthesis
model has a set of nodes V = {φ,y} representing either known or unknown quantities; and
the directed edges E represent dependencies between nodes. Each ‘child’ node is indepen-
dent of its ‘siblings’ conditional on their direct ‘parents’. The joint distribution of all nodes
V is the product of the conditional distributions of each node given its direct parents. An
example DAG of an evidence synthesis model is given in Figure 1(i). Circles denote unknown
quantities: either basic parameters θ that are ‘founder’ nodes at the top of a DAG having
a prior distribution (double circles); or functional parameters ψ. Squares denote observed
quantities, solid arrows represent stochastic distributional relationships, and dashed arrows
represent deterministic functional relationships. This DAG could be extended to more com-
plex hierarchical priors and models, where repetition over variables is represented by ‘plates’,
rounded rectangles around the repeated nodes, labelled by the range of repetition. In gen-
eral, the set V may be larger than the set of basic and functional parameters, including also
other intermediate nodes in the DAG, for example unit-level parameters in a hierarchical
model. For brevity, from here on we will abbreviate any DAG to the notation G(φ,y).
2.1 Network meta-analysis
Network meta-analysis (NMA) is a specific type of evidence synthesis (Salanti, 2012), that
generalises meta-analysis from the synthesis of studies measuring a treatment effect (e.g. of
treatment B versus treatment A in a randomised clinical trial), to the synthesis of data on
more than two treatment arms. The studies included in the NMA may not all measure the
same treatment effects, but each study provides data on at least two of the treatments. For
example, considering a set of treatments {A,B,C,D}, the network of trials may consist of
studies of different “designs”, i.e. with different subsets of the treatments included in each
trial (Jackson et al., 2014), such as {ABC,ABD,BD,CD}. As with meta-analysis, NMA
models can be implemented in either a two-stage or single-stage approach, as described more
comprehensively elsewhere (Salanti, 2012; Jackson et al., 2014). Here we concentrate on a
single-stage approach, where the original data Y Jdi for each treatment J of study i of design
d are available. A full likelihood model specifies
Y Jdi ∼ f(pJdi | wJdi)
for some distribution f(·) and treatment outcome pJdi with associated information wJdi. For
example, if the data are numbers of events out of total numbers at risk of the event, then wJdi
might be the denominator for treatment J . We might assume the data are realisations of a
Binomial random variable, Y Jdi ∼ Bin(wJdi, pJdi), where the proportion pJdi is a function of a
study-specific baseline αdi representing a design/study-specific baseline treatment Bd and a
study-specific treatment contrast (log odds ratio) µBdJdi , through a logistic model, logit(p
J
di) =
αdi + µ
BdJ
di . The intercept is αdi = logit(p
Bd
di ). To complete the model specification requires
parameterisation of the treatment effects µAJdi . A common effect model, for a network-wide
reference treatment A, is given by
µAJdi = η
AJ (1)
for each J 6= A, i.e. assumes that all studies of all designs measure the same treatment
effects. The ηAJ are basic parameters, of which there are the number of treatments in the
network minus 1, representing the relative effectiveness of treatment J compared to the
network baseline treatment A. All other contrasts ηJK , J,K 6= A are functional parameters,
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defined by assuming a set of consistency equations ηJK = ηAK − ηAJ for each J,K 6= A.
These equations define a transitivity property of the treatment effects. The extension to a
random-effects model, still under the consistency assumption, implies
µAJdi = η
AJ + βAJdi (2)
where usually the random effects βAJdi , reflecting between-study heterogeneity, are assumed
normally distributed around 0, with a covariance structure defined as a square matrix Σβ such
that all entries on the leading diagonal are σ2β and all remaining entries are σ
2
β/2 (Salanti,
2012; Jackson et al., 2015). Figure A.1 of the Supplementary Material shows the DAG
structure of both the common and random effects models for a full likelihood setting where
the outcome is binomial. The set of basic parameters is denoted ηb = (η
AJ)J 6=A and the
corresponding set of functional parameters is denoted ηf = (η
JK = ηAK − ηAJ)J,K 6=A. Note
that the common-effect model is a special case of the random-effects model. In the Bayesian
paradigm, we specify prior distributions for the basic parameters ηb, the (nuisance) study-
specific baselines αdi, and in the case of the random treatment effects model, the common
standard deviation parameter σβ in terms of which the variance-covariance matrix Σβ is
defined. Note that any change in parameterisation of the model, for example changing
treatment labels, will affect the joint prior distribution, making invariance challenging or
even impossible in a Bayesian setting.
A smoking cessation example Dias et al. (2010), amongst many others (Lu and Ades,
2006; Higgins et al., 2012; Jackson et al., 2015), considered an NMA of studies of smoking
cessation. The network consists of 24 studies of 8 different designs, including 2 three-arm
trials. Four smoking cessation counselling programs are compared (Figure 2): A no interven-
tion; B self-help; C individual counselling; D group counselling. The data (Supplementary
Material Table A.1) are the number of individuals out of those participating who have suc-
cessfully ceased to smoke at 6-12 months after enrollment. Here we fit the common- and
random-effect models under a consistency assumption and diffuse priors: Normal(0, 102) on
the log-odds scale for ηb and αdi; and Uniform(0, 5) for σβ. We find (Supplementary Ma-
terial Table A.2) that the deviance information criterion (DIC, Spiegelhalter et al. (2002))
prefers the random-effect model, suggesting it is necessary to explain the heterogeneity in
the network. The estimates of the treatment effects from the random-effect model are both
somewhat different and more uncertain than those from the common-effect model, agree-
ing with estimates found by others, including Dias et al. (2010). Moreover, the posterior
expected deviance for the random-effect model, Eθ|y(D) = 54, is slightly larger than the
number of observations (50), suggesting still some lack of fit to the data.
A single node-split model This residual lack of fit and the general potential in NMA for
variability between groups of direct and indirect information from multiple studies that is
excess to between-study heterogeneity (“inconsistency”, Lu and Ades (2006)) has motivated
various approaches to the detection and resolution of inconsistency (Lumley, 2002; Lu and
Ades, 2006; Dias et al., 2010; Higgins et al., 2012; White et al., 2012; Jackson et al., 2014).
Dias et al. (2010) apply the idea of node-splitting, based on Marshall and Spiegelhalter
(2007), to the NMA context, splitting a single mean treatment effect ηJK in the random ef-
fects consistency model (2). A DAG is partitioned into direct evidence from studies directly
comparing J and K versus indirect evidence from all remaining studies. Specifically, for any
study i of design d that directly compares J and K, the study-specific treatment effect is
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expressed in terms of the direct treatment effect: µJKdi = η
JK
Dir + β
JK
di ; whereas the indirect
version of the treatment effect is estimated from the remaining studies via the consistency
equation: ηJKInd = η
AK − ηAJ . The posterior distribution of the contrast or inconsistency pa-
rameter δJK = ηJKDir−ηJKInd is then examined to check posterior support for the null hypothesis
δJK = 0.
Multiple node-splits Although the single node-split approach in Dias et al. (2010) has
been extended to automate the generation of different single node-splitting models for conflict
assessment (van Valkenhoef et al., 2016), the simultaneous splitting of multiple nodes in a
NMA has not yet been considered. In section 4.1, we use multiple splits to investigate conflict
in the smoking cessation network beyond heterogeneity, accounting for the multiplicity.
2.2 Generalised evidence synthesis
As further illustration of systematic conflict detection, we consider an evidence synthesis
approach to estimating HIV prevalence in Poland, among the exposure group of men who
have sex with men (MSM) (Rosinska et al., 2016). The data aggregated to the national level
are given in Supplementary Material Table A.3. There are three basic parameters to be
estimated: the proportion of the male population who are MSM, ρ; the prevalence of HIV
infection in the MSM group, pi; and the proportion of those infected who are diagnosed, κ
(Figure 3(a)).
Likelihood The total population of Poland, N = 15, 749, 944, is considered fixed. The
remaining 5 data points y1, . . . , y5 directly inform, respectively: ρ; prevalence of diagnosed
infection piκ; prevalence of undiagnosed infection pi(1− κ); and lower (DL) and upper (DU)
bounds for the number of diagnosed infections D = Nρpiκ (Figure 3(a), Supplementary
Material Table A.3). These data are modelled independently as either Binomial (y1, y2, y3)
or Poisson (y4, y5).
Priors The number diagnosed D is constrained a priori to lie between the stochastic
bounds DL and DU , which in turn are given vague log-normal priors. Since D is already
defined as a function of the basic parameters, the constraint is implemented via introduction
of an auxiliary Bernoulli datum of observed value 1, with probability parameter given by a
functional parameter c = Pr(DL ≤ D ≤ DU) (Figure 3(a)). The basic parameters ρ, pi and
κ are given independent uniform prior distributions on [0, 1].
Exploratory model criticism This initial analysis reveals a lack of fit to some of the
data (Supplementary Material Table A.3), with particularly high posterior mean deviances
for the data informing ρ and piκ. This lack of fit in turn may suggest the existence of conflict
in the DAG (Spiegelhalter et al., 2002). In Rosinska et al. (2016), conflict between evidence
sources was not directly considered or formally measured, instead resolving the lack of fit
by modelling potential biases in the data in a series of sensitivity analyses. By contrast, in
Section 4.2 we systematically assess the consistency of evidence coming from the prior model
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and from each likelihood contribution, by splitting the DAG at each functional parameter
(Figure 3(b)).
3 Methods
3.1 A single conflict p-value
Briefly, as in Presanis et al. (2013), consider partitioning a DAG G(φ,y) into two inde-
pendent partitions, at a separator node φ. The separator could either be a founder node,
i.e. a basic parameter, or a node internal to the DAG, and is split into two copies φa
and φb, one in each partition (Figure 1(ii,iii)). Suppose that partition G(φa,ya) contains
the data vector ya and provides inference resulting in a posterior distribution p(φa | ya),
and that similarly partition G(φb,yb) results in p(φb | yb). The aim is to assess the
null hypothesis that φa = φb. For φ taking discrete values, we can directly evaluate
p(φa = φb | ya,yb). If the support of φ is continuous, we consider the posterior prob-
ability of δ = h(φa) − h(φb), where h(·) is a function that transforms φ to a scale for
which a uniform prior is appropriate. The two-sided “conflict p-value” is defined as c =
2×min {Pr{pδ(δ | ya,yb) < pδ(0 | ya,yb)}, 1− Pr{pδ(δ | ya,yb) < pδ(0 | ya,yb)}}, where pδ
is the posterior density of the difference δ, so that the smaller c is, the greater the conflict.
3.2 Defining multiple hypothesis tests of conflict
Generalising now to multiple tests of conflict, suppose that G(φ,y) is partitioned into Q
independent sub-graphs, G1(φ1,y1), . . . ,GQ(φQ,yQ), where each disjoint subset of the data
yq, q ∈ 1, . . . , Q is chosen to identify part of the basic parameter space θq = (θq1, . . . , θqbq),
where bq is the number of basic parameters in partition q. Note that θq ⊂ φq for each
q ∈ 1, . . . , Q, whereas the complementary subset φq \ θq consists of functional and other
non-basic parameters. To test the consistency of information provided by each partition
about a set of J separator nodes (φ
(s)
1 , . . . , φ
(s)
J ) ⊆ φ from the original model, a set of
constrasts δj = (δj1, . . . , δjCj) is formed for each j ∈ 1, . . . , J , one contrast per pair of
partitions in which φj appears. A maximum of
(
Q
2
)
contrasts are possible for each separator,
i.e. Cj ≤
(
Q
2
)
. Each contrast δjc is defined as
δjc = hj(φjqA | yA)− hj(φjqB | yB)
for the pair of partitions c = {qA, qB} and node-split copies {φjqA , φjqB}. The functions hj(·)
are functions that transform the separator nodes {φjqA , φjqB} to an appropriate scale for a
uniform (Jeffreys) prior to be applicable, if either is a founder node in either partition.
Denote the separator nodes in each partition by φ(s)q = {φjq, j ∈ 1, . . . ,mq, q ∈ 1, . . . , Q},
where mq ≤ J is the number of separator nodes in partition q. Writing these nodes as
a stacked vector φS = (φ
(s)
1 , . . . ,φ
(s)
Q ) = (φ11, . . . , φm11, φ12, . . . , φm22, . . . , φ1Q, . . . , φmQQ)
T ,
and the transformed version as φH = h(φS), the total set of contrasts is
∆ = (δ1, . . . , δJ)
T = C∆
TφH
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for an appropriate contrast matrix of 1s and 0s, C∆
T . Note that not every separator node
necessarily appears in every partition, so although φH has maximum length J × Q, in
practice, its lengthm =
∑Q
q=1mq ≤ J×Q. The contrast matrixC∆T therefore has dimension
p×m, so that it maps from the space of the m separator nodes (including node-split copies)
to that of the p =
∑J
j=1Cj contrasts. A test for consistency of the information in each
partition may be expressed as a test of the null hypothesis that
H0 : ∆ = C∆
TφH = 0 (3)
3.3 Asymptotic theory
Using standard asymptotic theory (Bernardo and Smith, 1994, see also derivation in Sup-
plementary Material Appendix B), it can be shown that if the joint posterior distribution
of all parameters φ in all partitions is asymptotically multivariate normal (i.e. if the prior
is flat enough relative to the likelihood), and if ∂∆(φ)
∂φ
= C∆
T is non-singular with contin-
uous entries, then the posterior mean of ∆ is ∆ = C∆
TφH
a≈ C∆T φˆH and the posterior
variance-covariance matrix of ∆ is S∆
a≈ C∆TVHC∆, where: φˆH is the maximum like-
lihood estimate of φˆH ; the matrix VH = Jh(φˆS)
TVSJh(φˆS); Jh(φˆS) is the Jacobian of
the transformation h(φS); and VS is a blocked diagonal matrix consisting of the inverse
observed information matrices for the separator nodes in each partition along the diagonal.
The posterior summaries ∆ and S∆, i.e. the Bayes’ estimator under a mean-squared error
Bayes’ risk function and corresponding variance-covariance matrix, may therefore be used
under the general simultaneous inference framework of Hothorn et al. (2008); Bretz et al.
(2011) to construct a multiplicity-adjusted test that ∆ = 0.
3.4 Simultaneous hypothesis testing
Given the estimator ∆ and corresponding variance-covariance matrix S∆, define a vec-
tor of test statistics T n = D
−1/2
n (∆ − ∆), where n is the dimension of the data y and
Dn = diag(S∆). Then it can be shown (Hothorn et al., 2008; Bretz et al., 2011) that
Tn tends in distribution to a multivariate normal distribution, T n
a∼ Nm(0,R), where
R := D−1/2n S∆D
−1/2
n ∈ Rm,m is the posterior correlation matrix for the vector (length
m) of contrasts ∆. Under the null hypothesis (3), T n = D
−1/2
n ∆
a∼ Nm(0,R), and hence,
assuming S∆ is fixed and known, the authors show that a global χ
2-test of conflict can be
formulated:
X2 = T TnR
+T n
d−→ χ2(Rank(R))
where the superscript + denotes the Moore-Penrose inverse of the corresponding matrix and
Rank(R) is the degrees of freedom. Importantly, it is also possible to construct multiply-
adjusted local (individual) conflict tests, based on the m z−scores corresponding to T n and
the null distribution of the maximum of these, Zmax, (Hothorn et al., 2008; Bretz et al.,
2011). This latter null distribution is obtained by integrating the limiting m−dimensional
multivariate normal distribution over [−z, z] to obtain the cumulative distribution function
P(Zmax ≤ z). The individual conflict p-values are then calculated as P(|zk| < Zmax), k ∈
1, . . . ,m, with a corresponding global conflict p-value (an alternative to the χ2-test) given
by P(|zmax| < Zmax).
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4 Examples
We now illustrate the idea of systematic multiple node-splitting to assess conflict in our two
motivating examples. All analyses were carried out in OpenBUGS 3.2.2 (Lunn et al., 2009)
and R 3.2.3 (R Core Team, 2015). We use the R2OpenBUGS package (Sturtz et al., 2005) to
run OpenBUGS from within R and the multcomp package (Bretz et al., 2011) to carry out the
simultaneous local and global max-T tests.
4.1 Network meta-analysis
Consider first a NMA in general, and for simplicity, assume there are no multi-arm trials
and a common-effect model (equation (1)) for the data. The basic parameters ηb form a
spanning tree of the network of evidence (Figure 2), i.e. a graph with no cycles, such that
each node in the network can be reached from every other node, either directly or indirectly
through other nodes (van Valkenhoef et al., 2012). Multiple possible partitionings of the
evidence network exist, so a choice must be made (Figure 2). Suppose the spanning tree
ηb is identifiable by a set of evidence Y b containing outcomes from all trials designed to
directly estimate the treatment effects in ηb. Then every treatment effect is identifiable from
Y b, by definition of a spanning tree and the fact that each treatment effect represented by
edges outside the spanning tree is a functional parameter in the set ηf , equal to a linear
combination of the basic parameters. The data Y b therefore indirectly inform the functional
parameters ηf , whereas the remaining data, Y f = Y \Y b directly inform ηf . A comparison
between the direct and indirect evidence on ηf is therefore possible, to assess conflict between
the two types of evidence. The network is split into two partitions, {ηDirf ,Y f} (the “direct
evidence partition”, DE) and {ηIndf ,Y b} (the “spanning tree partition”, ST) and the direct
and indirect versions of the functional parameters compared: ∆ = ηDirf − ηIndf . Depending
on the studies that are in the DE partition, the basic parameters ηb may also be weakly
identifiable in the DE partition, due to prior information. Since a NMA model may be
formulated as a DAG, this Direct/Indirect partitioning is equivalent to a multi-node split in
the DAG at the functional parameters (Supplementary Material Figure A.2).
Generalising now to more complex situations, if the direct data Y f form a sub-network of
evidence, the question arises of whether these data should be split into further partitions,
by identifying a spanning tree for the sub-network. Then the vector ∆ of contrasts to test
would involve comparisons between more than two partitions, e.g. for three partitions:
∆ =
(
η1f − η2f ,η1f − η3f ,η2f − η3f
)T
If we now consider a random rather than common heterogeneity effects model (equation (2)),
a decision must be made on how to handle the variance components in Σβ. One approach
would be to split the variance components simultaneously with the means, so that ∆ also
includes contrasts for the variances. Alternatively, if the variance components are not well
identified by the evidence in a partition, a common variance component could be assumed.
Such commonality could potentially allow for feedback between partitions, since they would
not be fully independent (Marshall and Spiegelhalter, 2007; Presanis et al., 2013).
Finally, for multi-arm trials, the key consideration is that multi-arm studies should have
8
internal consistency, and hence their observations should not be split between partitions. A
choice must therefore be made whether to initially include multi-arm data in the ST data
Y b, in the DE data Y f , or in a third partition of their own. In the latter case, any study-
specific treatment effect µJKdi , where d is a multi-arm design, could be compared at least with
the ST partition, where ηJK is definitely identified. Potentially, it could also be compared
simultaneously with the DE partition, if the edge JK is identifiable in the DE partition. The
comparison can be made even if JK is not identifiable, or only weakly identifiable from the
prior, but if the prior is diffuse, then no conflict will be detected due to the uncertainty. Such
a comparison is not therefore particularly meaningful, unless we are interested in prior-data
conflict.
Smoking cessation example To illustrate concretely the above issues, we consider first
the spanning tree (AB,AC,AD) corresponding to the parameters ηb = {ηAB, ηAC , ηAD}
for the smoking cessation example. Figures 2(b-d) demonstrate different ways of splitting
the evidence based on this spanning tree, depending on how we treat the evidence from
multi-arm trials. In Figures 2(b,c), we consider just two partitions, with the multi-arm evi-
dence either left in the ST partition {ηIndf ,Y b} or included in the DE partition {ηDirf ,Y f},
respectively. We compare the direct and indirect evidence on each of the edges or treat-
ment comparisons (BC,BD,CD). In Figure 2(d), we consider a series of spanning trees
((AB,AC,AD), (BC,BD) and (CD)), together with a final partition consisting of evidence
from multi-arm trials, resulting in four partitions.
We also consider an alternative choice of spanning tree, (AB,AC,BD), as in Figures 2(e,f).
In these two models, we again make a choice between including the multi-arm evidence
in either the ST or DE partitions and compare the evidence in each partition on edges
(AD,BC,CD). In all cases, we assume random heterogeneity effects and make the choice
to assume common variance components across the partitions, splitting only the means.
Table 1 gives posterior mean (sd) estimates of the treatment effects (log odds ratios) for
edges outside the spanning tree, from each partition, where the subscript 1 denotes the ST
partition and 2 denotes the DE partition for the two-partition models (b,c,e,f). For the
four-partition model (d), 1-3 denote the sequential spanning tree partitions and 4 the multi-
arm trial partition. Also given, for each edge outside the original spanning tree, are the
posterior mean (sd) differences between partitions and both the local and global posterior
probabilities of no difference, adjusted for the multiple tests and their correlation. First, note
that the global test of no conflict varies by model, and hence by what partitions of evidence
are compared with each other: the posterior probability of no conflict in model (b) is 94.7%,
compared to only 23.4% and 27.4% for models (c) and (e). These latter two models appear to
detect some mild evidence of conflict, despite the large uncertainty in many of the partition-
specific treatment effect estimates, with several of the posterior standard deviations of the
same order of magnitude as the corresponding posterior means, if not larger. The DIC is
also slightly smaller for the two models (c) and (e) which detect potential conflict, compared
to those that don’t. This lack of invariance of the global test to the partitions employed
suggests it is not enough to rely on a single node-splitting model to search for conflict in
a DAG. Moreover, it motivates looking at local tests for conflict in different node-splitting
models, to locate the specific items of evidence that may conflict with each other.
A closer look at the local posterior probabilities of no conflict for each edge outside the initial
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spanning tree reveals that the potential conflict detected by models (c) and (e) involves edges
including treatment D (posterior probabilities 17.8% and 18.6% for edges BD and CD in
model (c), 12.4% and 10.5% for edges AD and CD in model (e)). Each of these four
local tests involves a partition where the estimated treatment effect for the relevant edge is
implausibly large (> 6 on the log odds ratio scale, i.e. > 400 on the odds ratio scale) and
where the sample sizes of the studies involved are small (e.g. studies 7, 20, 23 and 24 in
Supplementary Material Table A.1).
Unlike models (c), (e) and (f), where in both partitions, each sub-network spans all 4 treat-
ments, in models (b) and (d), the spanning tree chosen, (AB,AC,AD), is such that for each
sub-network outside the spanning tree, not all the treatments are included (Figure 2). This
results in a lack of identifiability for the basic parameters ηb in partition 2 of model (b) and
in partitions 2 and 3 of model (d) (Table 1), where their estimates are dominated by their
diffuse prior distribution (Normal(0, 102) on the log odds ratio scale). There is therefore
no potential for detecting conflict about the basic parameters ηb, only about the functional
parameters ηf .
The different results obtained from each of the five models are understandable, since each
model partitions the evidence in a different way, and the detection of conflict relies on the
conflicting evidence being in different rather than the same partitions. However, where the
same evidence is in the same partition for different models — for example, the evidence
directly informing the AC edge in models (c) and (d) — approximately the same estimate is
reached in each model, as expected (0.81(0.26) in model (c), 0.82(0.28) in model (d), Table
1).
4.2 HIV prevalence evidence synthesis
Figure 3(b) demonstrates the multiple node-splits we make to systematically assess conflict
in the original DAG of Figure 3(a), separating out the contributions of the prior model and
each likelihood contribution. These node-splits result in 5 partitions, with 6 contrasts to test
for equality to zero. Denoting the nodes in the “prior” partition (above the red arrows in
Figure 3(b)) by the subscript p and the nodes in each “likelihood” partition (below the red
arrows in Figure 3(b)) by d, the vector of contrasts to test is then
∆ = (h(ρp)− h(ρd), h(pipκp)− h([piκ]d), h(pip(1− κp))− h([pi(1− κ)]d),
g(DLp)− g(DLd), g(DUp)− g(DUd), g(Dp)− g(Dd)))T
where h(·) and g(·) denote the logit and log functions respectively. These contrasts are
represented by the red dot-dashed arrows in Figure 3(b). In the “prior” partition, the
priors given to the basic parameters are those of the original model (Section 2.2). In each
“likelihood” partition, the basic parameters are given Jeffreys’ priors so that the posteriors
represent only the likelihood. These priors are Beta(1/2, 1/2) for the proportions and p(DBd) ∝
1/D
1/2
Bd
for the lower and upper bounds (B = L,U) for D. Dd is given a Uniform prior
between DLd and DUd .
Figure 4 shows the posterior distributions of the contrasts ∆, where 0 lies in these distribu-
tions and the corresponding unadjusted (pU) and multiply-adjusted (pA) individual conflict
p-values testing for equality to 0. A global χ2-squared (Wald) test gives a conflict p-value
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of 0.001, suggesting conflict exists somewhere in the DAG. Examining the individual unad-
justed (naive) conflict p-values would suggest prior-data conflict at the upper bound for the
number diagnosed DU (posterior probability of zero difference is pU = 0.008) and hence at
the number diagnosed itself, D (pU = 0.039), as well as possibly at the proportion at risk,
ρ (pU = 0.078). However, once the correlation between the individual tests has been taken
into account, the posterior probabilities of no conflict increase for all contrasts, albeit the
probabilities are still low for DU and D, at pA = 0.175 and pA = 0.058 respectively. Note that
the posterior contrasts in Figure 4 are slightly non-normal, hence we interpret the adjusted
posterior probabilities of no conflict as exploratory, rather than as absolute measures.
Examining closer the posterior distributions of the “prior” and “likelihood” versions of the
node D (Supplementary Material Figure A.3, upper panel), we visualise better the prior-
data conflict: the “likelihood” version lies very much in the lower tail of the “prior” version.
This is in spite of – or rather because of – the flat Uniform priors of the prior model, which
translate into a non-Uniform implied prior for the function Dp = Nρppipκp.
The “saturated” model splitting apart each component of evidence in the DAG allows us to
assess prior-data conflict in this model, but not conflict between different combinations of
the likelihood evidence, due to lack of identifiability: in each likelihood partition in Figure
3(b), clearly only the parameter directly informed by the data, whether basic or functional,
can be identified. To assess consistency of evidence between likelihood terms, we employ a
cross-validatory “leave-n-out” approach, for n = 1 and n = 2, splitting in each case the rel-
evant nodes directly informed by the left-out data items. Note that other possibilities exist,
such as splitting at the basic parameters, depending on which data are left out. Table 2 gives
unadjusted (pU) and various multiply-adjusted (pAW , pAL, pAA) individual posterior proba-
bilities of no difference between nodes split between partitions 1 (the “left-out” evidence)
and 2 (the remaining evidence). These posterior probabilities highlight inconsistency in the
network of evidence {y1, y2, y4, y5}, i.e. informing the three nodes ρ, piκ and D = Nρpiκ.
Splits at these three nodes demonstrate low posterior probabilities of no difference in the
“leave-1-out” models (A), (B) and (E), and in the “leave-2-out” models (B), (C), and (J) in
particular. There is no potential for the evidence y3 on the prevalence of undiagnosed infec-
tion pi(1−κ) to conflict with any other evidence, since pi and κ are not separately identifiable
from the remaining evidence {y1, y2, y4, y5} alone. Hence all of the posterior probabilities of
no difference concerning the node pi(1− κ) are high.
The conflict in the {y1, y2, y4, y5} network is well illustrated by the node-split model (J),
where the count data on the lower and upper bounds for the D are “left out” in partition
1. Supplementary Material Figure A.3 (lower panel) shows the posterior distributions for
each of DL, DU and D in both partitions. Since in partition 2 the data on the limits for D
have been excluded, the posterior distributions for the bounds (solid black and red lines) are
flat and hugely variable. Despite this, the posterior distribution for D2 is relatively tightly
peaked, due to the indirect evidence on D2 provided by the data informing ρ2 and pi2κ2. It
is this indirect evidence that conflicts with the direct evidence informing D1 via the data
{y4, y5} on the bounds for D1.
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5 Discussion
We have proposed here the systematic assessment of conflict in an evidence synthesis, in
particular accounting for the multiple tests for consistency entailed, through the simultaneous
inference framework proposed by Hothorn et al. (2008); Bretz et al. (2011). We have chosen
the max-T tests that allow both for multiply-adjusted local and global testing simultaneously.
Note that the use of this (typically classical) simultaneous inference framework relies on the
asymptotic multivariate normality of the joint posterior distribution. In cases where the
likelihood does not dominate the prior, resulting in a skewed or otherwise non-normal poste-
rior, we treat the results of conflict analysis as exploratory, rather than absolute measures of
conflict. If the posterior is skewed but still uni-modal, a global, implicitly multiply-adjusted,
test for conflict can be formulated in terms of the Mahalanobis distance of each posterior
sample from their mean, as we proposed in Presanis et al. (2013). This is a multivariate
equivalent of calculating the tail area probability for regions further away from the posterior
mean than the point 0. However, the Mahalanobis-based test does not allow us to obtain
local tests for conflict, nor does it apply in the case of a multi-modal posterior. In the latter
case, kernel density estimation could be used to obtain the multivariate tail area probability,
although such estimation is computationally challenging for large posterior dimension.
Although generalised evidence syntheses have mostly been carried out in a Bayesian frame-
work, there are examples (e.g. Commenges and Hejblum, 2013) that are either frequentist or
not fully Bayesian. In the NMA field, maximum likelihood and Bayesian methods are both
common (e.g. White et al., 2012; Jackson et al., 2014). An advantage of the simultaneous
inference framework (Hothorn et al., 2008; Bretz et al., 2011) is that, given any estimator ∆
of a vector of differences and its corresponding variance-covariance matrix S∆, regardless of
the method used to obtain the estimates, the global and local max-T tests can be formulated.
Conflict p-values can be seen as cross-validatory posterior predictive checks (Presanis et al.,
2013). There is a large literature on various types of Bayesian predictive diagnostics, in-
cluding prior-, posterior- and mixed-predictive checks (e.g. Box, 1980; Gelman et al., 1996;
Marshall and Spiegelhalter, 2007). A key issue much discussed in this literature is the lack of
uniformity of posterior predictive p-values under the null hypothesis (Gelman, 2013), with
such p-values conservative due to the double use of data. Much work has therefore been
devoted to either alternative p-values (e.g. Bayarri and Berger, 2000) or post-processing of
p-values to calibrate them (e.g. Steinbakk and Storvik, 2009). Gelman (2013) argues that
the importance of uniformity depends on the context in which the model checks are con-
ducted: in general non-uniformity is not an issue, but if the posterior predictive tests rely
on parameters or imputed latent data, then care should be taken. Since conflict p-values
are cross-validatory, the issue of conservatism and the double use of data does not apply. In
fact, for a wide class of standard hierarchical models, G˚asemyr (2016) has demonstrated the
uniformity of the conflict p-value.
As illustrated by both applications, the choice of different ways of partitioning the evidence
in a DAG can lead to different conclusions over the existence of conflict. This is to be ex-
pected when considering the local conflict p-values, since conflicting evidence may need to be
in different partitions in order to be detectable. This is analogous to the idea of “masking” in
cross-validatory outlier detection, where outliers may not be detected if multiple outliers ex-
ist (Chaloner and Brant, 1988). In the case of the global tests for conflict, the NMA example
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showed that these are also not invariant to the choice of partition. In the NMA literature, al-
ternative methods accounting for inconsistency include models that introduce “inconsistency
parameters” that absorb any variability due to conflict beyond between-study heterogeneity
(Lu and Ades, 2006; Higgins et al., 2012; Jackson et al., 2014). Higgins et al. (2012); Jackson
et al. (2014) have pointed out that the apparent algorithm that Lu and Ades (2006) follow for
identifying inconsistency parameters does not guarantee that all such parameters are identi-
fied, nor that the Lu-Ades model is invariant to the choice of baseline treatment. The authors
further posit, and more recently have proved (Jackson et al., 2015), that their “design-by-
treatment interaction model”, which introduces an inconsistency parameter systematically
for each non-baseline treatment within each design, contains each possible Lu-Ades model
as a sub-model. In related ongoing work, we note that each Lu-Ades model corresponds to a
particular choice of node-splitting model, one being a reparameterisation of the other. The
lack of invariance of results of testing for inconsistency from one Lu-Ades model to another
is therefore not surprising, since, as we illustrated here, different choices of node-splitting
model correspond to different partitions of evidence being compared. The lack of invariance
of a global test for conflict to the choice of node-splitting model, although unsurprising, is
perhaps unsatisfactory: however, as we illustrated in this paper, this lack clearly emphasises
the need for a more comprehensive and systematic assessment of conflict throughout a DAG,
both at a local level and across different types of node-split model, than just a single global
test can provide. We therefore recommend that although a global test may be an initial
step in any conflict analysis, to be sure of detecting any potential conflict requires testing
for conflict throughout a DAG. One strategy is to start from splitting every possible node
in the DAG, as we did in the HIV example, before looking at more targeted leave-n-out ap-
proaches. The design-by-treatment interaction model provides a way of doing so and we are
further investigating the relationship of the (fixed inconsistency effects) design-by-treatment
interaction model to such a “saturated” node-splitting model.
Note that in the NMA example considered here, we have concentrated on a “contrast-based”
as opposed to “arm-based” parameterisation (Hong et al., 2016; Dias and Ades, 2016). Also,
we have considered the case where each study has a study-specific baseline treatment Bd and
the network as a whole has a baseline treatment A. However, alternative parameterisations
could be considered, such as using a two-way linear predictor with main effects for both
treatment and study, treating the counter-factual or missing treatment designs as missing
data (Jones et al., 2011; Piepho et al., 2012). Although we have not yet explored alternative
parameterisations, we posit that systematic node-splitting could be equally well applied.
As with any cross-validatory work, the systematic assessment of conflict at every node in a
DAG can quickly become computationally burdensome as a model grows in dimension. An
area for future research is the systematic analysis of conflict using efficient algorithms (Lunn
et al., 2013; Goudie et al., 2015) in a Markov melding framework (Goudie et al., 2016) which
allows for an efficient modular approach to model building.
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Figure 1: (i) Example DAG G(V ,E) showing a generic evidence synthesis. (ii) & (iii)
Example node-split at separator node φ: (ii) original model G(φ,y); (iii) node-split model.
In (ii): the data y = {yφ,yφ} comprise data yφ that are direct descendents of φ; and the
remaining data yφ. In (iii): when splitting G(φ,y) into partitions a and b, the data vector
yφ is split into ya,φ and yb,φ, whereas yφ remains only in partition a. The partition a data
are therefore ya = {ya,φ,yφ} and the partition b data are yb = yb,φ.
17
Table 1: Multiply adjusted posterior mean (sd) estimates of conflict between partitions,
for each model (b)-(f) respectively. In the two-partition models (b,c,e,f), partition 1 is the
spanning tree (indirect) evidence partition and partition 2 is the direct data partition. In
model (d), partitions 1-3 are the sequential spanning trees and partition 4 is the multi-arm
study partition.
ST: AB,AC,AD AB,AC,BD
Model: (b) (c) (d) (e) (f)
Posterior: Mean SD Mean SD Mean SD Mean SD Mean SD
AB1 0.472 (0.489) 0.338 (0.534) 0.329 ( 0.568) 0.259 (0.429) 0.334 (0.566)
AB2 -0.415 (5.276) 0.319 (0.983) -0.230 ( 5.849) 6.261 (3.251) 1.513 (1.041)
AB3 -0.044 (10.009)
AB4 0.456 ( 1.247)
AC1 0.877 (0.262) 0.814 (0.261) 0.828 ( 0.280) 0.812 (0.238) 0.824 (0.272)
AC2 -0.165 (5.262) 0.615 (0.866) -0.379 ( 5.848) 6.173 (3.140) 1.496 (0.835)
AC3 0.114 ( 7.051)
AC4 0.784 ( 0.956)
AD1 1.010 (0.598) 9.337 (4.999) 9.508 ( 5.330) 0.908 (0.794) 1.748 (1.526)
AD2 0.262 (5.266) 0.679 (0.871) 0.871 ( 5.859) 12.712 (6.225) 3.102 (1.690)
AD3 0.319 ( 7.044)
AD4 0.439 ( 0.956)
∆AD1−2 -11.804 (6.268) -1.354 (2.279)
pAD1−2 0.124 0.806
BC1 0.405 (0.527) 0.476 (0.590) 0.499 ( 0.633) 0.553 (0.461) 0.490 (0.629)
BC2 0.251 (0.808) 0.296 (0.577) -0.149 ( 1.015) -0.087 (0.951) -0.017 (0.693)
BC3 0.158 (12.270)
BC4 0.329 ( 0.957)
∆BC1−2 0.155 (0.963) 0.180 (0.821) 0.649 ( 1.198) 0.641 (1.059) 0.507 (0.937)
∆BC1−3 0.341 (12.290)
∆BC1−4 0.171 ( 1.161)
pBC1−2 0.986 0.971 0.979 0.807 0.839
pBC1−3 1.000
pBC1−4 1.000
BD1 0.538 (0.691) 8.999 (5.031) 9.180 ( 5.357) 0.649 (0.530) 1.414 (1.173)
BD2 0.678 (0.809) 0.360 (0.569) 1.101 ( 1.026) 6.451 (3.083) 1.589 (0.802)
BD3 0.363 (12.255)
BD4 -0.017 ( 0.948)
∆BD1−2 -0.140 (1.067) 8.639 (5.069) 8.079 ( 5.444)
∆BD1−3 8.817 (13.149)
∆BD1−4 9.196 ( 5.430)
pBD1−2 0.991 0.178 0.491
pBD1−3 0.952
pBD1−4 0.355
CD1 0.133 (0.594) 8.523 (5.011) 8.680 ( 5.337) 0.095 (0.778) 0.924 (1.553)
CD2 0.427 (0.680) 0.063 (0.460) 1.250 ( 1.438) 6.539 (3.198) 1.606 (1.081)
CD3 0.204 ( 0.771)
CD4 -0.345 ( 0.714)
∆CD1−2 -0.294 (0.902) 8.459 (5.033) 7.430 ( 5.526) -6.443 (3.287) -0.682 (1.893)
∆CD1−3 8.476 ( 5.385)
∆CD1−4 9.025 ( 5.378)
pCD1−2 0.943 0.186 0.588 0.105 0.934
pCD1−3 0.430
pCD1−4 0.365
Global p 0.947 0.234 0.700 0.274 0.733
DIC 98.843 95.420 96.354 95.745 98.351
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Table 2: Results from “leave-n-out” node-split models for the Polish HIV data. pU denotes
the unadjusted conflict p-value; pAW is the p-value adjusted for the multiple tests carried
out within each model (A)-(J) for the leave-2-out approach; pAL is the p-value adjusted for
the 23 tests carried out in all models (A)-(J) for the leave-2-out approach; and pAA is the
p-value adjusted for 28 tests carried out in all leave-1-out models (A)-(E) and all leave-2-out
models (A)-(J).
Model Partition 1 Partition 2 Node split pU pAW pAL pAA
Leave-1-out
(A) y1 {y2, y3, y4, y5} ρ < 0.0001 0.0060 0.0311
(B) y2 {y1, y3, y4, y5} piκ < 0.0001 0.0047 0.0246
(C) y3 {y1, y2, y4, y5} pi(1− κ) 0.6201 0.9857 1.0000
(D) y4 {y1, y2, y3, y5} DL 0.1257 0.6242 0.9934
(E) y5 {y1, y2, y3, y4} DU < 0.0001 0.5852 0.9890
Leave-2-out
(A) {y1, y2} {y3, y4, y5} ρ 0.6972 0.7480 1.0000 1.0000
piκ 0.2209 0.2230 0.9842 0.9937
(B) {y1, y3} {y2, y4, y5} ρ < 0.0001 0.0023 0.0240 0.0294
pi(1− κ) 0.4906 0.7717 1.0000 1.0000
(C) {y2, y3} {y1, y4, y5} piκ < 0.0001 < 0.0010 < 0.0010 < 0.0010
pi(1− κ) 0.8322 0.9000 1.0000 1.0000
pi 0.9921 0.9490 1.0000 1.0000
κ 0.3329 0.6700 0.9998 1.0000
(D) {y1, y4} {y2, y3, y5} ρ < 0.0001 0.0779 0.5754 0.6499
DL 0.0783 0.2851 0.9705 0.9866
(E) {y1, y5} {y2, y3, y4} ρ 0.0745 0.1260 0.7614 0.8271
DU 0.0026 0.0949 0.6543 0.7276
(F) {y2, y4} {y1, y3, y5} piκ 0.4682 0.9590 1.0000 1.0000
DL 0.0869 0.3000 0.9764 0.9898
(G) {y2, y5} {y1, y3, y4} piκ 0.4420 0.6690 1.0000 1.0000
DU 0.0137 0.1970 0.9044 0.9434
(H) {y3, y4} {y1, y2, y5} pi(1− κ) 0.1471 0.3330 0.9855 0.9944
DL 0.1328 0.3280 0.9844 0.9938
(I) {y3, y5} {y1, y2, y4} pi(1− κ) 0.5237 0.8100 1.0000 1.0000
DU < 0.0001 0.2850 0.9702 0.9864
(J) {y4, y5} {y1, y2, y3} DL 0.1958 0.5117 0.9933 0.9978
DU < 0.0001 0.3963 0.9706 0.9866
D < 0.0001 0.0030 0.0213 0.0260
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Figure 2: Smoking cessation evidence network, under (a) a consistency assumption; (b)-(f)
inconsistency assumptions, where the evidence is partitioned in different ways. In (b), (c),
(e) and (f), the direct evidence (dashed lines) is compared with the indirect evidence (solid
lines) on each contrast where there is a dashed line. In (d), the evidence is separated into
three spanning trees and a fourth partition for the multi-arm trial evidence.
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Figure 3: (a) DAG of initial model for synthesising Polish HIV prevalence data. (b) DAG of
multiple node-split model comparing priors to each likelihood contribution. Note that the
square brackets are used in denoting the nodes in the likelihood partition ([piδ]d, [pi(1− δ)]d)
to emphasise the fact that these two nodes are independent parameters not functionally
related to each other.
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Figure 4: Posterior distributions of the contrasts ∆ for the HIV prevalence example. The
red lines denote 0 difference, pU is the unadjusted and pA the multiply-adjusted individual
conflict p-value respectively.
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Figure A.1: (a) DAG of NMA under assumptions of a common treatment effect ηJK (no
heterogeneity) and consistency ηJK = ηAK − ηAJ . (b) DAG of NMA under assumptions of
random treatment effects, to account for heterogeneity, and consistency.
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Table A.1: Smoking cessation data set
Study Design yA nA yA/nA yB nB yB/nB yC nC yC/nC yD nD yD/nD
1 AB 79 702 0.113 77 694 0.111 . . . . . .
2 AB 18 671 0.027 21 535 0.039 . . . . . .
3 AB 8 116 0.069 19 149 0.128 . . . . . .
4 AC 75 731 0.103 . . . 363 714 0.508 . . .
5 AC 2 106 0.019 . . . 9 205 0.044 . . .
6 AC 58 549 0.106 . . . 237 1561 0.152 . . .
7 AC 0 33 0.000 . . . 9 48 0.188 . . .
8 AC 3 100 0.030 . . . 31 98 0.316 . . .
9 AC 1 31 0.032 . . . 26 95 0.274 . . .
10 AC 6 39 0.154 . . . 17 77 0.221 . . .
11 AC 64 642 0.100 . . . 107 761 0.141 . . .
12 AC 5 62 0.081 . . . 8 90 0.089 . . .
13 AC 20 234 0.085 . . . 34 237 0.143 . . .
14 AC 95 1107 0.086 . . . 143 1031 0.139 . . .
15 AC 15 187 0.080 . . . 36 504 0.071 . . .
16 AC 78 584 0.134 . . . 73 675 0.108 . . .
17 AC 69 1177 0.059 . . . 54 888 0.061 . . .
18 ACD 9 140 0.064 . . . 23 140 0.164 10 138 0.072
19 AD 0 20 0.000 . . . . . . 9 20 0.450
20 BC . . . 20 49 0.408 16 43 0.372 . . .
21 BCD . . . 11 78 0.141 12 85 0.141 29 170 0.171
22 BD . . . 7 66 0.106 . . . 32 127 0.252
23 CD . . . . . . 12 76 0.158 20 74 0.270
24 CD . . . . . . 9 55 0.164 3 26 0.115
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Table A.2: Treatment effect posterior estimates (mean (sd)) for the common- and random-
effect models respectively, with deviance summaries: posterior mean deviance Eθ|y(D); de-
viance evaluated at posterior means D(Eθ|yθ); effective number of parameters pD; and de-
viance information criterion DIC.
Model: Common-effect Random-effect
µJK : Posterior mean Posterior sd Posterior mean Posterior sd
AB 0.224 (0.124) 0.496 (0.405)
AC 0.765 (0.059) 0.843 (0.236)
AD 0.840 (0.174) 1.103 (0.439)
BC 0.541 (0.132) 0.347 (0.419)
BD 0.616 (0.192) 0.607 (0.492)
CD 0.075 (0.171) 0.260 (0.418)
Eθ|y(D) 267 54
D(Eθ|yθ) 240 10
pD 27 44
DIC 294 98
Table A.3: Results from initial HIV model: observations; posterior mean (sd) estimates;
posterior mean deviance Eθ|y(D); deviance evaluated at posterior means D(Eθ|yθ); effective
number of parameters pD; and deviance information criterion DIC.
Parameter Data Estimates Deviance summaries
θ y n y/n yˆ θˆ Eθ|y(D) D(Eθ|yθ) pD DIC
ρ 35 1536 0.023 14.6 ( 1.5) 0.010 (0.001) 21.0 20.7 0.4 21.4
piκ 113 2840 0.040 92.5 ( 8.9) 0.033 (0.003) 5.5 4.4 1.1 6.5
pi(1− κ) 136 2725 0.050 136.7 (11.3) 0.050 (0.004) 1.0 0.0 1.0 2.0
DL 836 836.2 (28.9) 836.2 (28.9) 1.0 0.0 1.0 2.0
DU 5034 5054.3 (70.8) 5054.4 (70.8) 1.1 0.1 1.0 2.1
Total 29.5 25.1 4.4 33.9
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Figure A.2: DAG of common-effect network meta-analysis model, split into direct (DE) and
indirect (ST) evidence informing the functional parameters ηf , i.e. those edges outside of
the spanning tree formed by the basic parameters ηb.
26
−5 0 5 10 15
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
1.
2
log(Dp) vs log(Dd)
N = 30000   Bandwidth = 0.05
D
en
si
ty
log(Dp)
log(Dd)
5 6 7 8 9 10 11 12
0
2
4
6
8
log(D2) vs log(D1)
N = 30000   Bandwidth = 0.05
D
en
si
ty
log(DL2)
log(DL1)
log(DU2)
log(DU1)
log(D2)
log(D1)
Figure A.3: Upper panel: Posterior distributions of the nodes Dp and Dd for the HIV
prevalence example, on the log scale. The right-hand blue line denotes where the total
population of Poland (N = 15, 749, 944) lies, i.e. the maximum possible value a priori for
the number diagnosed. The left-hand blue line denotes the value log(N × 0.53), i.e. the
prior mean of log(Dp) = log(Nρppipκp). Lower panel: Posterior distributions of the nodes
DL1, DL2, DU1, DU2, D1 and D2 for the HIV prevalence “leave-2-out” node-split model (J), on
the log scale. The dashed lines represent the nodes in partition 1, i.e. the “left-out” partition,
where the posteriors are based only on the likelihood given by {y4, y5} and Jeffreys’ priors
for DL1, DU1. The solid lines give the corresponding posteriors in partition 2, i.e. based on
all the original model priors and on the dataset {y1, y2, y3}.
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B Asymptotics
Let p(θ1), . . . , p(θQ) denote the set of prior distributions for the basic parameters θq in each
partition q. Then by the independence of each partition, the joint posterior distribution of
all parameters φ in all partitions is
p(φ | y) =
Q∏
q=1
p(θq)p(yq | θq).
If the joint prior distribution is dominated by the likelihood, then asymptotically (Bernardo
and Smith, 1994), the joint posterior distribution of all nodes is multi-variate normal:
φ | y a∼ N∑
q nq
(
(φˆ1, . . . , φˆQ),V
)
where nq is the total number of parameters in partition q, whether basic or not, and V is
the inverse observed information matrix for the parameters φ. Since the vector of separator
nodes, φS = (φ
(s)
1 , . . . ,φ
(s)
Q ), is a subset of φ, their joint posterior is also multivariate
normal:
φS | y a∼ Nm
(
(φˆ
(s)
1 , . . . , φˆ
(s)
Q ),VS
)
(4)
where m =
∑
qmq is the total number of separator nodes, including node-split copies, and
VS is the appropriate sub-matrix of V . Since the partitions are independent, VS is a blocked
diagonal matrix consisting of the inverse observed information matrices for separator nodes
in each partition along the diagonal.
By theorem 5.17 of Bernardo and Smith (1994), since (4) holds and if Jh(φS) =
∂h(φS)
∂φS
is non-singular with continuous entries, then the posterior distribution of the transformed
separator nodes, φH = h(φS), is also asymptotically normal:
φH | y a∼ Nm
(
h(φˆ
(s)
1 , . . . , φˆ
(s)
Q ),Jh(φˆS)
TVSJh(φˆS)
)
The Jacobian Jh(φS) exists and is non-singular for the sorts of transformations we use in
practice, for example log and logit transformations.
A further application of theorem 5.17 of Bernardo and Smith (1994) results in a posterior
distribution of the contrasts ∆ that is also aymptotically multivariate normal, if ∂∆(φ)
∂φ
=
C∆
T is non-singular with continuous entries, which as a contrast matrix it is:
∆ | y a∼ Np
(
C∆
Th(φˆ
(s)
1 , . . . , φˆ
(s)
Q ),C∆
TJh(φˆS)
TVSJh(φˆS)C∆
)
(5)
= Np
(
C∆
T φˆH ,C∆
TVHC∆
)
for VH = Jh(φˆS)
TVSJh(φˆS). Asymptotically, therefore, the posterior mean ∆ = C∆
TφH
a≈
C∆
T φˆH and the posterior variance-covariance matrix of ∆ is S∆
a≈ C∆TVHC∆.
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